COMELLI, Marina
 Distribuzione geografica
Continente #
NA - Nord America 6.049
EU - Europa 2.199
AS - Asia 460
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 8
Totale 8.724
Nazione #
US - Stati Uniti d'America 5.990
UA - Ucraina 840
IT - Italia 324
DE - Germania 305
CN - Cina 285
FI - Finlandia 260
FR - Francia 143
IE - Irlanda 134
SE - Svezia 118
CA - Canada 59
SG - Singapore 59
TR - Turchia 41
GB - Regno Unito 37
IN - India 29
IR - Iran 27
VN - Vietnam 17
BE - Belgio 13
RU - Federazione Russa 11
EU - Europa 8
PL - Polonia 5
TG - Togo 5
CZ - Repubblica Ceca 4
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
GR - Grecia 1
KR - Corea 1
NG - Nigeria 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.724
Città #
Ann Arbor 832
Woodbridge 605
Jacksonville 599
Houston 572
Fairfield 502
Chandler 444
Dearborn 336
Ashburn 243
Wilmington 212
Seattle 160
Boardman 154
Princeton 135
Udine 133
Dublin 130
Cambridge 125
Beijing 124
Ottawa 47
Izmir 40
Singapore 40
San Diego 30
Ogden 29
Faenza 26
Des Moines 20
Norwalk 20
Hefei 18
Leawood 18
Nanjing 18
Dong Ket 17
New York 17
Redmond 17
Kunming 15
San Mateo 15
Washington 14
Brussels 13
Ardabil 12
Andover 11
Augusta 11
Jinan 11
Munich 11
Guangzhou 10
Los Angeles 10
Nanchang 10
Rome 10
Scafati 10
Toronto 9
Gorizia 8
Helsinki 8
Monmouth Junction 7
Milan 6
Mumbai 6
Pignone 6
Saint Petersburg 6
Chengdu 5
Fuzhou 5
Lavis 5
Lomé 5
Wuhan 5
Brno 4
Hebei 4
Ningbo 4
Padova 4
Quzhou 4
Zielona Góra 4
Albano Laziale 3
Baotou 3
Grafing 3
New Delhi 3
Shanghai 3
Shenyang 3
Simi Valley 3
Spilimbergo 3
Spinea 3
Zanjan 3
Zhengzhou 3
Bra 2
Carpi 2
Castellammare di Stabia 2
Clifton 2
Edinburgh 2
Hangzhou 2
Jesolo 2
Kashan 2
London 2
Maenza 2
Naples 2
Phoenix 2
Reggio Nell'emilia 2
Romans D'isonzo 2
Sacramento 2
Santa Croce sull'Arno 2
Schio 2
Shenzhen 2
Trieste 2
Venice 2
Verona 2
Winnipeg 2
Xian 2
Bremen 1
Cairo 1
Campoformido 1
Totale 6.013
Nome #
F1FO ATP synthase is expressed at the surface of embryonic rat heart-derived H9c2 cells and is affected by cardiac-like differentiation 192
Secretion of lysosomal hydrolases by cultured human amnion epithelial cells 142
Transformation by different oncogenes relies on specific metabolic adaptations 139
Mitochondrial Adaptations in Elderly and Young Men Skeletal Muscle Following 2 Weeks of Bed Rest and Rehabilitation 132
Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status 130
The inactivation of mitochondrial F1ATPase by H2O2 is mediated by iron ions not tightly bound in the protein 129
Immunity in patients treated with cis-platinum 125
Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. 122
Downmodulation of mitochondrial F0F1ATPsynthase by diazoxide in cardiac myoblasts: a dual effect of the drug 119
Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway 119
ATPase-INHIBITORY FACTOR 1 IS A PROGNOSTIC FACTOR IN LOW GRADE ASTROCYTOMAS 115
Apoptosis is induced by decline of mitochondrial ATP synthesis in erythroleukemia cells 114
Early impairment of kidney function after cisplatinum administration 113
Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma 109
Severe energy impairment consequent to inactivation of mitochondrial ATPsynthase as early event of cell death. A mechanism for the selective sensitivity to H2O2 of differentiating erythroleukemia cells 107
Proteomic analysis of F1F0-ATP synthase super-assembly in mitochondria of cardiomyoblasts undergoing differentiation to the cardiac lineage 107
Lyphocytes subpopulations in untreated patients with cancer 106
Caspase-independent apoptosis in Friend’s erythroleukemia cells: role of mitochondrial ATP synthesis impairment in relocation of apoptosis-inducing factor and endonuclease G 104
Cardiac differentiation promotes mitochondria development and ameliorates oxidative capacity in H9c2 cardiomyoblasts 102
IF1 distribution in HepG2 cells in relation to ecto F0F1ATPsynthase and calmodulin 97
Immunity in patients treated with cis-platinum. 96
Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function 96
Kidney glomerular disfunction in DDP-treated patients 93
Immunity during monochemotherapy with mitoxantrone: preliminary results 91
New insights in the mitochondrial localization of APE1, the major apurinic/apyrimidinic endonuclease in mammals 90
ATPase-INHIBITORY FACTOR 1 AND OXPHOS COMPLEXES IN HUMAN GLIOMAS 90
Mitochondrial bioenergetic profile of human hepatocarcinoma cell lines 87
Bone marrow toxicity and antitumor action of adriamycin in relation to the antioxidant effets of melatonin 86
Glucose-Modulated Mitochondria Adaptation in Tumor Cells: A Focus on ATP Synthase and Inhibitor Factor 1 86
Different Fe molecular species mediate selective H2O2-damage to different moieties of F0F1ATPsynthase in intact cells, isolated mitochondria or proteoliposomes 84
Mitochondrial and cell-surface F0F1ATPsynthase in innate and acquired cardioprotection 84
H2O2 induces apoptosis in heme-synthesizig erytrholeukemia cells with a mechanism indeoendent from nF-kB activation and mediated by decline in mitochondrial bioenergy 82
Valutazione nutrizionale in un campione di volontari obesi inclusi in un programma di intervento nutrizionale e di attività sportiva 81
A 99Tc-DTPA study on platinum nephrotoxicity: glomerular lesions 80
A 99mtc-DTPA study on platinum chronic nephrotoxicity: also glomerular lesions 79
Chemotherapy (CT) effects on lymphocytes subpopulations in cancer patients 79
Alcuni tests immunitoari in pazienti cancerosi, trattati con monochemioterapia con diidrossiantracenedione (DHAD) ad alto dosaggio 78
Melatonin increases the therapeutical index of adramycin 77
Immunity during monochemotherapy with mitoxantrone: preliminary results 76
Effects of 3-month high-intensity interval training vs. moderate endurance training and 4-month follow-up on fat metabolism, cardiorespiratory function and mitochondrial respiration in obese adults 75
Down-regulation of the mitochondrial ATP synthase in Friend's erythroleukemia cells induced to differentiation 74
Immunological study in untreated patients with breast cancer (BC) 74
Immunity in cancer patients during polychemotherapy (PCH) with or wirthout cyclophosphamide (CTX) 72
Exercise training in Tgαq*44 mice during the progression of chronic heart failure: cardiac vs. peripheral (soleus muscle) impairments to oxidative metabolism 72
GSK3β is a key regulator of the ROS-dependent necrotic death induced by the quinone DMNQ 71
Requirement of loosely bound Fe++/Fe+++ for the oxidative inactivation of F1ATPase 69
Effects of thymopentin in cancer patients treated with chemotherapy 69
Early and progressive glomerular kidney toxicity during cis-platinum therapy 69
Treatment of shingomyelinase deficiency by repeated implantations of amniotic epithelial cells 68
Is the severe energy impairment caused by H2O2 responsible for the decrease of proliferative efficienty of differentiated Friend's erythroleukemia cells? 68
Endogenous pro-oxidant status and H2O2-mediated impairment of cell mitochondrial functions, ATP content and proliferative capacity 68
Studio immunologico in cancerose sottoposte a CEP-chemioterapia, con o senza immunomodulatore 67
Manipulation of iron and energy status of cells as a tool fot triggering apoptosis. Key role for inactivation of mitochondrial ATP synthase 66
Kidney glomerular disfunction in DDP-treated patients 66
Differentiation potentiates oxidant injury to mitochondria by hydrogen peroxide in Friend erythroleukemia cells 66
Inhibition of mitochondrial ATP synthase leading to ATP loss as early irreverible event of cell death 65
Immunological study in patients with brest cancer during chemotherapy (CT) including cyclophosphamide (CTX) 64
Studio immunologico durante terapia con platino (DDP) in pazienti cancerosi 62
Alcuni test immunitari in pazienti con malattie linfoproliferative, in rapporto all'età 62
Early impairment of kidney function after platinum administration 62
Immunity in bresat cancer (BC) patients during DDP chemotherapy (CT) 62
The challenge by oxidant stress to mitochondrial ATP synthase in intact erythroleukemia cells is enhanced by heme 61
Immunochanges during monochemotherapy in cancer patients 60
Chemioterapia antiblastica (CT) con /senza timopentina (random): effetti sull' immunità (I) in vivo e in vitro 59
Early and progressive glomerular kidney toxicity during is-platinum therapy 59
Aminoglutetimide nel carcinoma mammario metastatizzato 58
Implication of the lipophilic and hydrophilic moieties in the peroxide-induced oxidation of bovine heart mitochondrial H+ATP synthase 58
Mitochondria and cell susceptibility to oxidative damage as related to different iron homeostasis and redox status: a study on Friend's erythroleukemia cells induced to differentiation 58
Down-modulation of mitochondrial ATP synthase by diazoxide in cardiac myoblasts 58
Kidney function in cancer patients during chemotherapy (CT) with DD-platinum (DDP) and mitomycin c(MMC) 57
Trattamento di 4 casi di malattia di Niemann-Pick tipo B, mediante trapianto di cellule epiteliali amniotiche 57
Redox status of Freind's cells influences NK-kB binding activity induced by H2O2 57
Melatonin and oxidative damage in mice liver induced by the prooxidant antitumor drug, Adriamycin 57
Melatonin increases the therapeutic index of the antitumor anthracycline, adriamycin 56
An immunological study in 44 cancer patients with or without synthetic tymic immunomodulators 56
Inactivation of mitochondrial ATPsynthase through manipulation of iron status as a tool for triggering apoptosis 56
Lymphocytes subpopulations (LS) and other immunological parameters in untreated patients with cancer 56
La malattia di Gaucher: studio di un gruppo familiare del Friuli 55
Proteomic analysis of the supramolecular organization of F0F1ATPsynthase in bovine heart mitochondria 55
Pro-oxidant conditions in Friend's cells during erythroid differentiation 54
Mitochondrial bioenergetic profile and metabolic adaptation of human hepatocarcinoma cell lines 54
Immunity in untreated patients with brest cancer 53
Characteristics of iron ion bionding sites in mitochondrial F1ATPase 53
Effetti del cis-platino (DDP) in monochemioterapia su alcuni parametri immunologici 52
Different mechanisms of H2O2-dependent damage to mitochondrial F0F1ATPsynthase mediated by different intracellular iron chelates 52
Cellule epiteliali amniotiche: bioreattori con secrezione specifica per la terapia di sostituzione enzimatica 51
Immunità in vivo in pazienti cancerosi trattati con mitoxantrone (M) in monochemioterapia 50
Immunity in patients with lung cancer (LC) during various chemotherapy (CT) regimens 50
Active Regulation of ATPsynthase by the Inhibitor Protein IF1 in Heart 50
Cardiomyoblasts differentiation as a model to define the molecular determinants of assembly/stability of F0F1ATP synthase dimers 50
Metabolic plasticity of tumor cells: analysis of ATP synthase and IF1 in the glucose modulation of the oxidative metabolism 49
Peripheral impairments of oxidative metabolism after a 10-day bed rest are upstream of mitochondrial respiration 49
Glutathione status and malondialdheyde production as markers of oxidative stress occurred during erythroid differentiation 47
Tossicità renale glomerulo-tubulare da chemioterapia con cis-platino (DDP) 46
Anemia indotta dal cis-platino in monochemiotearpia. Studio preliminare 46
Morphological and functional mitochondrial changes upon in vitro cardiomyogenesis 46
Studio immunologico durante terapia con platino (DDP) 45
Immunità in pazienti con CA polmonare (Ca P) durante chemioterapia (CT) 45
Caspase-independent apoptosis is triggered by stimuli impairing mitochondrial ATP synthesis in Friend's erythroleukemia cells 45
H2O2 triggers caspase-independent apoptosis in D-FELC via mitochondrial bioenergy impairment 43
Totale 7.592
Categoria #
all - tutte 30.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.958 0 0 84 242 135 408 217 276 134 233 41 188
2020/20211.421 43 147 13 165 35 171 25 160 327 44 237 54
2021/2022990 19 149 26 91 62 14 35 61 10 149 196 178
2022/2023986 154 87 28 104 103 270 2 53 124 7 20 34
2023/2024365 46 28 13 7 52 63 16 8 52 27 15 38
2024/2025193 47 145 1 0 0 0 0 0 0 0 0 0
Totale 8.814